Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
about
What is the best way to measure renal fibrosis?: A pathologist’s perspectiveComplement cascade and kidney transplantation: The rediscovery of an ancient enemyDirect and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney TransplantationMacrophages: contributors to allograft dysfunction, repair, or innocent bystanders?MHC class I signaling: new functional perspectives for an old moleculeBK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infectionReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesABO incompatible renal transplants: Good or bad?The involvement of SMILE/TMTC3 in endoplasmic reticulum stress responseReduced PARP1 as a Serum Biomarker for Graft Rejection in Kidney TransplantationEffects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi-omics Approach.Long-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies.Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): reproducibility of polyomavirus immunohistochemistry in kidney allografts.Heat Shock Protein 90α Is a Potential Serological Biomarker of Acute Rejection after Renal Transplantation.TSI ultrasound elastography for the diagnosis of chronic allograft nephropathy in kidney transplanted patients.Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.Pros and cons for C4d as a biomarker.Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft SurvivalKIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantationRenal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Clinical aspects: focusing on key unique organ-specific issues of renal transplantation.An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.Correlation between PKB/Akt, GSK-3β expression and tubular epithelial-mesenchymal transition in renal allografts with chronic active antibody-mediated rejection.Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease.Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model.The role of B cells in solid organ transplantation.Antithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipientsExpansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunctionCell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation.The tacrolimus metabolism rate influences renal function after kidney transplantationCytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.Morphometric and visual evaluation of fibrosis in renal biopsiesThe kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.BK virus nephropathy in renal transplant recipients.Urinary calprotectin and posttransplant renal allograft injury.Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.
P2860
Q26796641-C3764697-6ECC-4288-AC2E-13010DE3F43AQ26829790-38E502C9-9AFF-4573-B2D4-386E73F0D0E3Q26863724-EDBE260E-9276-4966-BD1F-4BED2AF0BFACQ26998846-920D3D84-C25A-4478-B873-F7D0B4A89D0EQ27000194-6FAE7C15-4600-4F8A-845A-BCB2C701C771Q28070240-EA1D722F-1975-44C1-B178-240431D52094Q28080994-9E871DA2-ED6B-4DF4-B43A-A302B3286019Q28236829-8D572CE1-94F7-460B-B558-379E071E1240Q28478144-C2CAFE56-6ED7-41DA-AF61-71DFBBA1AB38Q30177456-2BF7115C-20AA-4A26-A487-E8CE8E8562B2Q30252315-D6EC6B44-D4F0-4C5F-963F-957BE54D885FQ30278721-8EF02899-5A6F-40A5-8930-E41F3BBD6240Q30371017-91A6E8A6-3B31-4201-BBCA-F0AE7E136DEDQ30373788-ABE7738F-B95E-45FA-9077-9F075C3F0F0BQ30396112-FBA0B98B-7EFA-43E8-B80E-4F198C090C67Q30405394-8CFC3201-2C2F-4233-AB0D-42452D3ABF5DQ30544649-75649206-8C5D-4D69-8150-5003D114D661Q30681903-1CC11702-4F3D-4A31-BB34-7824FBF15FB0Q33365693-5D396A5F-6A41-4395-962F-3A30913AF339Q33396969-86C5B0CE-C51D-49C7-9193-DF4051A08702Q33412327-9B4DBC6C-1DD4-447A-B197-84CAFE005C4CQ33414342-13638D80-754A-448C-A305-815B6A2CC11BQ33724166-342B7556-2C05-4678-9AFE-69CB05272812Q33776912-F78A6898-3BF1-44C6-8CB1-4F0E6D469BEFQ33891669-788CCFB4-AB06-414C-8B3E-AD889325E8FDQ33891696-582F68F6-3B0B-48EF-892B-2DF267A1B9A9Q33930084-B2AA2B9F-F9B0-4BA1-AA28-3D191B931773Q33974650-DBBC30B5-F88B-446A-9FD5-584666B672A6Q34030907-CFFD2488-0E4E-4917-9FBA-F7486E95DD03Q34217788-C896B694-876F-40A2-904C-B7F16142E4A3Q34260097-9178ABF3-BE8D-4C97-B194-25898FA4CE77Q34269169-33C9CB0A-6074-4169-8385-C4DB6527084AQ34289498-0E77C42A-862F-4983-ADA2-72FA9A1E6688Q34395610-493F7E57-A7AF-4B98-9C21-1F7DE36DE4C5Q34427661-3C28814E-FB8D-48DC-A122-D6A1C9CE802FQ34457313-4A1E5C10-4C9D-46EF-8D8E-C2696318E9DEQ34489123-C140BFB2-2F48-4FFF-896A-03BE35F83243Q34509585-D5A39041-1C7A-4ED2-B852-9FADE19A9CB9Q34525420-EBB30459-FDC2-45F7-8FD0-E08CB3312DEEQ34663943-CDB0B6CD-543D-468B-9678-A52999E6542E
P2860
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Banff '09 meeting report: anti ...... ation of Banff working groups.
@en
Banff '09 meeting report: anti ...... ation of Banff working groups.
@nl
type
label
Banff '09 meeting report: anti ...... ation of Banff working groups.
@en
Banff '09 meeting report: anti ...... ation of Banff working groups.
@nl
prefLabel
Banff '09 meeting report: anti ...... ation of Banff working groups.
@en
Banff '09 meeting report: anti ...... ation of Banff working groups.
@nl
P2093
P1476
Banff '09 meeting report: anti ...... tation of Banff working groups
@en
P2093
A J Demetris
B A Wasowska
B J Nankivell
C Drachenberg
C Legendre
P304
P356
10.1111/J.1600-6143.2009.02987.X
P407
P577
2010-01-29T00:00:00Z